Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.
Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time, following FDA approval of clinical trials
Twin Health has raised $50 million in funding for the continued development of its ‘digital twin’ platform, which aims to provide a model of a patient’s unique metabolism.
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year